Mohamed Raslan

633 total citations
28 papers, 204 citations indexed

About

Mohamed Raslan is a scholar working on Infectious Diseases, Pharmacology and Surgery. According to data from OpenAlex, Mohamed Raslan has authored 28 papers receiving a total of 204 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Infectious Diseases, 5 papers in Pharmacology and 3 papers in Surgery. Recurrent topics in Mohamed Raslan's work include COVID-19 Clinical Research Studies (9 papers), SARS-CoV-2 and COVID-19 Research (6 papers) and Antibiotics Pharmacokinetics and Efficacy (3 papers). Mohamed Raslan is often cited by papers focused on COVID-19 Clinical Research Studies (9 papers), SARS-CoV-2 and COVID-19 Research (6 papers) and Antibiotics Pharmacokinetics and Efficacy (3 papers). Mohamed Raslan collaborates with scholars based in Egypt, India and Brazil. Mohamed Raslan's co-authors include Nagwa A. Sabri, Ayman Salama, Mohammed Elmowafy, Wafaa I. El‐Eraky, Tapani Viitala, Sally A. El Awdan, Ragab Said, Kornelia Zaręba, Ayman Al‐Hendy and Michał Ciebiera and has published in prestigious journals such as Advances in experimental medicine and biology, Pharmaceutics and AAPS PharmSciTech.

In The Last Decade

Mohamed Raslan

22 papers receiving 202 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mohamed Raslan Egypt 6 61 49 34 30 29 28 204
Juntao Yin China 11 19 0.3× 63 1.3× 44 1.3× 82 2.7× 6 0.2× 33 377
Linyu Deng China 12 31 0.5× 16 0.3× 16 0.5× 96 3.2× 13 0.4× 12 484
Srinivas Hebbar India 8 19 0.3× 94 1.9× 11 0.3× 61 2.0× 10 0.3× 26 271
Sin Wi Ng Malaysia 8 69 1.1× 38 0.8× 21 0.6× 118 3.9× 12 0.4× 9 292
Kiran Kumar Mudnakudu-Nagaraju India 9 21 0.3× 33 0.7× 20 0.6× 70 2.3× 5 0.2× 19 309
Umesh D. Laddha India 10 17 0.3× 81 1.7× 12 0.4× 64 2.1× 5 0.2× 24 294
S. Preetha India 8 34 0.6× 4 0.1× 4 0.1× 76 2.5× 16 0.6× 63 308
Xingxing Li China 11 28 0.5× 47 1.0× 25 0.7× 172 5.7× 2 0.1× 33 383
Hanaa Tashkandi Saudi Arabia 8 18 0.3× 5 0.1× 9 0.3× 53 1.8× 2 0.1× 21 200
Armin Sadeghi Iran 7 51 0.8× 12 0.2× 199 5.9× 137 4.6× 11 492

Countries citing papers authored by Mohamed Raslan

Since Specialization
Citations

This map shows the geographic impact of Mohamed Raslan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohamed Raslan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohamed Raslan more than expected).

Fields of papers citing papers by Mohamed Raslan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mohamed Raslan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohamed Raslan. The network helps show where Mohamed Raslan may publish in the future.

Co-authorship network of co-authors of Mohamed Raslan

This figure shows the co-authorship network connecting the top 25 collaborators of Mohamed Raslan. A scholar is included among the top collaborators of Mohamed Raslan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mohamed Raslan. Mohamed Raslan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Raslan, Mohamed, Christopher Kanaan, Linnea M. Baudhuin, et al.. (2025). The Burden of Cardiac Arrhythmias in Loeys-Dietz Syndrome. JACC Advances. 4(11). 102269–102269.
2.
Raslan, Mohamed, et al.. (2024). Applications of Proteomics in Probiotics Having Anticancer and Chemopreventive Properties. Advances in experimental medicine and biology. 1443. 243–256. 1 indexed citations
3.
Raslan, Mohamed, Nagwa A. Sabri, Khalid J. Alzahrani, et al.. (2024). Different modalities to manage rheumatoid arthritis: an A to Z story. Future Science OA. 10(1). 2 indexed citations
4.
Raslan, Mohamed, Nagwa A. Sabri, Khalid J. Alzahrani, et al.. (2023). COVID-19 Vaccination in Pediatrics: Was It Valuable and Successful?. Vaccines. 11(2). 214–214. 2 indexed citations
5.
Raslan, Mohamed, et al.. (2023). Associations between Nutrigenomic Effects and Incidences of Microbial Resistance against Novel Antibiotics. Pharmaceuticals. 16(8). 1093–1093. 1 indexed citations
6.
Raslan, Mohamed, et al.. (2022). Virtual and on Site Vaccination Clinics of COVID-19. Will it be Applicable?. Acta Scientific Pharmaceutical Sciences. 141–144. 2 indexed citations
7.
Raslan, Mohamed, et al.. (2021). Changes in the Pharmacokinetics and Pharmacodynamics of Sildenafil in Cigarette and Cannabis Smokers. Pharmaceutics. 13(6). 876–876. 7 indexed citations
8.
Raslan, Mohamed, et al.. (2021). Variant Under Investigation (VUI) and Severity of COVID-19 Third Wave. Is there a Correlation?. Acta Scientific Pharmaceutical Sciences. 5(11). 55–58. 1 indexed citations
9.
Ali, Mohamed, Mohamed Raslan, Michał Ciebiera, Kornelia Zaręba, & Ayman Al‐Hendy. (2021). Current approaches to overcome the side effects of GnRH analogs in the treatment of patients with uterine fibroids. Expert Opinion on Drug Safety. 21(4). 477–486. 20 indexed citations
10.
Raslan, Mohamed, et al.. (2021). Development of a Novel Method for Determination of Risperidone in Pharmaceutical Products and its Quality Control Application. Acta Scientific Pharmaceutical Sciences. 5(3). 101–109. 1 indexed citations
11.
Raslan, Mohamed, et al.. (2020). Quantification of Cyclobenzaprine in Human Plasma by LC/MS/MS and its Pharmacokinetics Application. Acta Scientific Pharmaceutical Sciences. 4(11). 90–96. 1 indexed citations
12.
Raslan, Mohamed, et al.. (2020). Management of Second Wave of COVID 19 with Ledipasvir / Sofosbuvir Combination. Will it Work? A Review Article. Saudi Journal of Medical and Pharmaceutical Sciences. 6(10). 654–657. 3 indexed citations
13.
Raslan, Mohamed, et al.. (2020). Sex-mediated effects of ACE2 and TMPRSS2 on the incidence and severity of COVID-19; The need for genetic implementation. Current Research in Translational Medicine. 68(4). 149–150. 17 indexed citations
14.
15.
16.
Raslan, Mohamed, et al.. (2020). Hydroxychloroquine and Management of COVID-19 What is behind its Accurate Detection in its Pharmaceutical Products?. Saudi Journal of Medical and Pharmaceutical Sciences. 6(10). 644–653.
17.
Sabri, Nagwa A., et al.. (2020). Association of COVID-19 with genotyping ApoEe4 and APOBEC3B. 4(1). 1 indexed citations
18.
Sabri, Nagwa A., et al.. (2020). Management protocols for COVID-19: Will it include targeting ADAM 17.. 4(1). 1 indexed citations
19.
Raslan, Mohamed, et al.. (2020). Cefixime and Management Protocols for COVID-19 Second Wave. Does its Accurate Detection in Human Plasma Make Sense?. Acta Scientific Pharmaceutical Sciences. 5(1). 46–53. 2 indexed citations
20.
Elmowafy, Mohammed, Mohamed Raslan, Ayman Salama, et al.. (2015). Enhancement of Bioavailability and Pharmacodynamic Effects of Thymoquinone Via Nanostructured Lipid Carrier (NLC) Formulation. AAPS PharmSciTech. 17(3). 663–672. 106 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Juntao Yin Breakdown of academic impact, for papers by Linyu Deng Breakdown of academic impact, for papers by Srinivas Hebbar Breakdown of academic impact, for papers by Sin Wi Ng Breakdown of academic impact, for papers by Kiran Kumar Mudnakudu-Nagaraju Breakdown of academic impact, for papers by Umesh D. Laddha Breakdown of academic impact, for papers by S. Preetha Breakdown of academic impact, for papers by Xingxing Li Breakdown of academic impact, for papers by Hanaa Tashkandi Breakdown of academic impact, for papers by Armin Sadeghi
Rankless by CCL
2026